ABBOTT LABORATORIES — Director's Dealing 2014

Feb 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-01-31

Reporting Person: Funck Robert E (Vice President, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-31	Common shares without par value	M	2137	$31.6081	Acquired	62365	Direct
2014-01-31	Common shares without par value	M	5715	$33.88	Acquired	68080	Direct
2014-01-31	Common shares without par value	M	1546	$35.08	Acquired	69626	Direct
2014-01-31	Common shares without par value	S	2598	$36.19	Disposed	67028	Direct
2014-01-31	Common shares without par value	S	5608	$36.20	Disposed	61420	Direct
2014-01-31	Common shares without par value	S	1192	$36.21	Disposed	60228	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-31	Option (right to buy)	$31.6081	M	2137	Disposed	2014-02-19	Common shares (2137)	Direct
2014-01-31	Option (right to buy)	$33.88	M	5715	Disposed	2014-02-19	Common shares (5715)	Direct
2014-01-31	Option (right to buy)	$35.08	M	1546	Disposed	2014-02-19	Common shares (1546)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15475	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.